EAI

What this means for you

Registered since 16 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98120597

Registration number

8070034

Mark type

Stylized text

Filed

07 Aug 2023

Published for opposition

22 Oct 2024

Registered

16 Dec 2025

Attorney of record

Naira Simmons

Goods and services

• Class 005 — Pharmaceuticals: Clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for testing biopsy and other tissue samples for use in disease detection, namely, breast cancer; clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for breast cancer surveillance, namely, for measuring amounts of genomic and other biomarkers contacted with the reagent, such as estrogen receptor (ER), progesterone receptor (PR) associated biomarkers, and other suitable biomarkers for monitoring breast cancer occurrence, recurrence, response to various chemotherapies, hormone therapies, radiation therapies, or other suitable treatments

Owner

• Delphi Diagnostics, Inc., Houston, TX, US
• Delphi Diagnostics, Inc., Houston, TX, US
• Delphi Diagnostics, Inc., Houston, TX, US

Prosecution history

• 16 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 16 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
• 26 Nov 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 26 Nov 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 22 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
• 03 Jun 2025 — USE AMENDMENT FILED
• 22 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 03 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
• 03 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 22 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 22 Oct 2024 — PUBLISHED FOR OPPOSITION
• 02 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 12 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 12 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 12 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE